Eco Animal Health Group PLC
EAH
Company Profile
Business description
Eco Animal Health Group PLC is manufacturing and supply animal health products globally. It has presence in Corporate/UK, China & Japan, North America, S & SE Asia, Latin America, Europe, and Rest of World. Majority of revenue comes from North America. Its solution includes Aivlosin is a proprietary, patented medication which is effective against both respiratory and enteric diseases in pigs and poultry; ECOVAXXIN MS a poultry vaccine targeting Mycoplasma synoviae; Parasite Solutions Internal and external parasites can cause a variety of health problems in all animal.
Contact
The Grange, 100 High street
Southgate
LondonN14 6BN
GBRT: +44 2084478899
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
213
Stocks News & Analysis
stocks
CBA earnings: Business lending powers on, but costs and credit bear watching
Our view after the bank reports first quarter earnings.
stocks
Apple earnings review: Revenue beats estimates as memory crunch threatens margins
Apple shares are trading at record highs after posting solid results.
stocks
Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil
We’re reducing our long-term revenue estimates.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,204.50 | 69.70 | -0.75% |
| CAC 40 | 8,368.91 | 7.55 | 0.09% |
| DAX 40 | 26,749.95 | 21.93 | -0.08% |
| Dow JONES (US) | 52,266.29 | 30.80 | -0.06% |
| FTSE 100 | 10,902.56 | 39.47 | 0.36% |
| HKSE | 23,637.60 | 370.95 | -1.55% |
| NASDAQ | 25,080.31 | 285.78 | -1.13% |
| Nikkei 225 | 61,142.35 | 322.99 | 0.53% |
| NZX 50 Index | 14,173.68 | 85.55 | -0.60% |
| S&P 500 | 7,543.17 | 49.23 | -0.65% |
| S&P/ASX 200 | 9,082.20 | 64.60 | -0.71% |
| SSE Composite Index | 3,634.35 | 21.48 | -0.59% |